↓ Skip to main content

Article

Overview of attention for article published in Arthritis Research & Therapy, January 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
2 news outlets
twitter
6 tweeters
facebook
3 Facebook pages
wikipedia
9 Wikipedia pages
video
3 video uploaders

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
137 Mendeley
citeulike
3 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Published in
Arthritis Research & Therapy, January 2006
DOI 10.1186/ar1876
Pubmed ID
Authors

LeslieG Cleland, MichaelJ James, SusannaM Proudman

Abstract

There is a general belief among doctors, in part grounded in experience, that patients with arthritis need nonsteroidal anti-inflammatory drugs (NSAIDs). Implicit in this view is that these patients require the symptomatic relief provided by inhibiting synthesis of nociceptive prostaglandin E2, a downstream product of the enzyme cyclo-oxygenase (COX), which is inhibited by NSAIDs. However, the concept of 'safe' NSAIDs has collapsed following a multiplicity of observations establishing increased risk for cardiovascular events associated with NSAID use, especially but not uniquely with the new COX-2-selective NSAIDs. This mandates greater parsimony in the use of these agents. Fish oils contain a natural inhibitor of COX, reduce reliance on NSAIDs, and reduce cardiovascular risk through multiple mechanisms. Fish oil thus warrants consideration as a component of therapy for arthritis, especially rheumatoid arthritis, in which its symptomatic benefits are well established. A major barrier to the therapeutic use of fish oil in inflammatory diseases is ignorance of its mechanism, range of beneficial effects, safety profile, availability of suitable products, effective dose, latency of effects and instructions for administration. This review provides an evidence-based resource for doctors and patients who may choose to prescribe or take fish oil.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 1 <1%
Australia 1 <1%
Brazil 1 <1%
India 1 <1%
United Kingdom 1 <1%
Japan 1 <1%
Unknown 131 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 30 22%
Researcher 22 16%
Student > Master 16 12%
Student > Ph. D. Student 15 11%
Other 7 5%
Other 32 23%
Unknown 15 11%
Readers by discipline Count As %
Medicine and Dentistry 50 36%
Agricultural and Biological Sciences 21 15%
Nursing and Health Professions 11 8%
Biochemistry, Genetics and Molecular Biology 6 4%
Social Sciences 5 4%
Other 24 18%
Unknown 20 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2022.
All research outputs
#1,333,010
of 21,682,700 outputs
Outputs from Arthritis Research & Therapy
#189
of 2,870 outputs
Outputs of similar age
#10,798
of 248,634 outputs
Outputs of similar age from Arthritis Research & Therapy
#11
of 210 outputs
Altmetric has tracked 21,682,700 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,870 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,634 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 210 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.